SCHEMBL372301

SCHEMBL372301

CCCCCCCN1C=CN(C)C1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GUSB P08236 2/20 0.38
EBP Q15125 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
PTGS1 P23219 3/20 0.36
PTGS2 P35354 3/20 0.36
MGLL Q99685 2/20 0.36
FAAH O00519 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
DNM1 Q05193 3/20 0.36
GNAI3 P08754 1/20 0.35
GNAO1 P09471 1/20 0.35
GNAI1 P63096 1/20 0.35
TSHR P16473 1/20 0.35
THRB P10828 1/20 0.35
TBXAS1 P24557 1/20 0.34
NPC1 O15118 2/20 0.33
GALR3 O60755 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL572164 1.00 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL2890409 1.00 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL899205 1.00 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL294133 1.00 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL4066620 1.00 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL4066198 1.00 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL4061744 1.00 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL92757 1.00 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL5305365 1.00 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2
SCHEMBL2219980 1.00 GUSB (0.38) GUSBEBPSIGMAR1PTGS1PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 578 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4650498-A1 FLUID CONTACTING DEVICE Aurotec GmbH (AT) 2025-11-19 EP claimed
EP-4470972-A1 PROCESS FOR PRODUCING ONIUM SALTS OF BIS(FLUOROSULFONYL)IMIDE SPECIALTY OPERATIONS FRANCE (FR) 2024-12-04 EP claimed
CN-119059497-A Process for the production of onium salts of bis (fluorosulfonyl) imide 法国特种经营公司 2024-12-03 CN claimed
US-20240262937-A1 Preparation of Chitin Nanocrystals and Nanowhiskers from Crustacean Biomass Using Ionic Liquid TEXAS TECH UNIVERSITY SYSTEM 2024-08-08 US claimed
CN-118291559-A Method for synthesizing bio-based pentanediamine by using ionic liquid to strengthen whole cell catalysis 中国科学院过程工程研究所 2024-07-05 CN claimed
CN-114315728-B Imidazole ionic liquid and application thereof in alcoholysis polymerization of 2, 5-furandicarboxylic acid ester 中国科学院大连化学物理研究所 2024-04-19 CN claimed
WO-2024078801-A1 CURABLE AND ELECTRICALLY DEBONDABLE ONE-COMPONENT (1K) STRUCTURAL ADHESIVE COMPOSITION HENKEL AG & CO. KGAA (DE) 2024-04-18 WO claimed
EP-4353760-A1 CURABLE AND ELECTRICALLY DEBONDABLE ONE-COMPONENT (1K) STRUCTURAL ADHESIVE COMPOSITION Henkel AG & Co. KGaA (DE) 2024-04-17 EP claimed
CN-117126683-A Separation method and system for aromatic hydrocarbon in diesel oil and related application 中国石油天然气集团有限公司 2023-11-28 CN claimed
CN-116297898-A Method for simultaneously detecting various alkyl imidazole ionic liquids in serum based on liquid chromatography-mass spectrometry 武汉轻工大学 2023-06-23 CN claimed
US-20090318734-A1 IONIC ADDITIVE FOR CATALYSIS IN BIPHASIC REACTION SYSTEMS THE UNIVERSITY COURT OF THE UNIVERSITY OF ST. ANDREWS (GB) 2009-12-24 US claimed
CN-101541673-A Process for purifying perfluorinated products DU PONT (US) 2009-09-23 CN claimed
CN-101454420-A Vapor compression using ionic liquids as compressor lubricants DU PONT (US) 2009-06-10 CN claimed
CN-101214954-A Method for preparing conductive single-layer graphite sheet modified by ionic liquid cation group UNIV NORTHEAST NORMAL (CN) 2008-07-09 CN claimed
EP-1362572-B1 Use of at least one particular organic salt for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment OREAL (FR) 2008-04-16 EP claimed
US-20070295478-A1 Vapor Compression Cycle Utilizing Ionic Liquid as Compressor Lubricant E. I. DU PONT DE NEMOURS AND COMPANY 2007-12-27 US claimed
US-20070297965-A1 PROCESS FOR PURIFYING PERFLUORINATED PRODUCTS E. I. DU PONT DE NEMOURS AND COMPANY 2007-12-27 US claimed
EP-1649894-A2 Composition comprising electrophilic monomers and organic salts, use for treatment of keratinic materials L'OREAL (FR) 2006-04-26 EP claimed
EP-1362572-A1 Cosmetic composition comprising at least one particular organic salt and its use for cleansing and/or conditioning keratinous materials, use of a particular organic salt as conditioning agent for said materials and process for cosmetic treatment L'OREAL (FR) 2003-11-19 EP claimed
WO-2003076366-A2 A METHOD FOR PREPARING ORGANIC FLUOROCOMPOUNDS CHEMTECH RESEARCH INCORPORATION (KR) 2003-09-18 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318734-A1 IONIC ADDITIVE FOR CATALYSIS IN BIPHASIC REACTION SYSTEMS WEE2, WEE1, ITK GUSB 4226/4885EBP 1664/4885SIGMAR1 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.